Walter A. Gilbert

Walter Gilbert, PhD, joined BioVentures Investors in 2003, after being an outside advisor to the firm since its inception, and is currently a Venture Partner.
He is a leading molecular biologist, and was the Carl M.
Loeb University Professor at Harvard University.
In 1975, Wally developed a method of rapid DNA sequencing for which he received the Nobel Prize in Chemistry in 1980.
Wally was a founder of Biogen, and served as Chairman and CEO until 1985.
While a member of the BioVentures Investors Fund I Board of Advisors, he co-founded Pintex Pharmaceuticals Inc., a Fund I portfolio company, and served as Chairman of the Board of Directors.
Formerly, he was a co-founder and Vice-Chairman of Myriad Genetics Inc. (NASDAQ: MYGN) and a co-founder and Chairman of Paratek Pharmaceuticals Inc. Wally was also a co-founder and Director of Memory Pharmaceuticals Inc., which was acquired by Roche, and served as a Director of Transkaryotic Therapies, which now goes by the name Shire Human Genetic Therapies.
Wally holds an AB in Chemistry and Physics from Harvard College, an MA in Physics from Harvard University, and a PhD in Mathematics from Cambridge University.
He has multiple honorary doctorates.